Development of the Multi-Drug-Loaded Implants Combined with Dual-Gene Transfected Bmscs Coating Based on 3d Bioprinting for the Treatment of Nonunion

Xinyi Zhang,Liang Sun,Guodong Wang,Zhigang Mei,Demeng Yang,Shixin Zheng,Ping Liu
DOI: https://doi.org/10.2139/ssrn.4110005
2022-01-01
SSRN Electronic Journal
Abstract:A 3D printing platform has been developed for the treatment of nonunion after fracture via the individualized multi-drug-loaded implants combined with dual-gene transfected bone mesenchymal stem cells (BMSCs) coating. A series of in vivo trials were conducted which closely mimicked real clinical conditions. It has been shown that 3D printed polylactic acid (PLA) implants are exceptional carriers for drugs and can be designed with finely tuned physical morphologies and controllable micropore structures. Their favorable biodegradability, cytotoxicity, blood compatibility, subacute toxicity and low sensitization have confirmed their biocompatibility and pharmaceutical properties. Furthermore, we have demonstrated that the individualized multi-drug-loaded plants combined with dual-gene transfection to BMSCs coating exhibits an anti-nonunion efficacy superior to traditional therapy through a series of in vivo tests according to clinical protocols. The proposed 3D printed drug delivery platform can simultaneously realize individual treatment, multi-drug delivery, long-term sustainable drug release, and non-reoperation in anti-nonunion treatment. Our studies enable the utilization of the 3D printing technique in the treatment of nonunion after fracture and guide future clinical trials. The established techniques and principles can also be adapted to the local therapy of other bone defect.
What problem does this paper attempt to address?